CTLLABHealthcare Service Provider
Clinitech Laboratory Ltd — Cash Flow Statement
₹35.00
-6.23%
Clinitech Laboratory Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -2.04 Cr | -2.49 Cr | 0.97 Cr | -0.56 Cr | — |
| Repayment Of Debt | -0.86 Cr | -0.17 Cr | — | — | — |
| Issuance Of Capital Stock | 4.89 Cr | 0.68 Cr | 0.00 | 0.00 | — |
| Capital Expenditure | -1.16 Cr | -1.21 Cr | -0.28 Cr | -1.51 Cr | — |
| End Cash Position | 3.07 Cr | 0.70 Cr | 0.78 Cr | 0.10 Cr | — |
| Beginning Cash Position | 0.70 Cr | 0.78 Cr | 0.10 Cr | 0.32 Cr | — |
| Changes In Cash | 2.37 Cr | -0.08 Cr | 0.68 Cr | -0.22 Cr | — |
| Financing Cash Flow | 3.98 Cr | 0.45 Cr | 0.09 Cr | 0.29 Cr | — |
| Interest Paid Cff | -0.04 Cr | -0.07 Cr | -0.06 Cr | -0.06 Cr | — |
| Net Common Stock Issuance | 4.89 Cr | 0.68 Cr | 0.00 | 0.00 | — |
| Common Stock Issuance | 4.89 Cr | 0.68 Cr | 0.00 | 0.00 | — |
| Net Issuance Payments Of Debt | -0.86 Cr | -0.17 Cr | 0.14 Cr | 0.35 Cr | — |
| Net Short Term Debt Issuance | -0.58 Cr | -0.12 Cr | 0.22 Cr | 0.47 Cr | — |
| Short Term Debt Payments | -0.58 Cr | -0.12 Cr | — | — | — |
| Net Long Term Debt Issuance | -0.29 Cr | -0.05 Cr | -0.07 Cr | -0.12 Cr | — |
| Long Term Debt Payments | -0.29 Cr | -0.05 Cr | — | — | — |
| Investing Cash Flow | -0.73 Cr | 0.75 Cr | -0.65 Cr | -1.47 Cr | — |
| Net Other Investing Changes | 1000.00 | 0.01 Cr | 1.49 Cr | 0.02 Cr | — |
| Interest Received Cfi | 0.13 Cr | 1000.00 | 0.02 Cr | 0.07 Cr | — |
| Net PPE Purchase And Sale | -0.86 Cr | -1.21 Cr | -0.28 Cr | -1.51 Cr | — |
| Sale Of PPE | 0.31 Cr | 0.00 | — | — | — |
| Purchase Of PPE | -1.16 Cr | -1.21 Cr | — | — | — |
| Operating Cash Flow | -0.88 Cr | -1.28 Cr | 1.25 Cr | 0.96 Cr | — |
| Taxes Refund Paid | -0.16 Cr | -0.14 Cr | -0.30 Cr | -0.21 Cr | — |
| Change In Working Capital | -1.57 Cr | -2.14 Cr | 0.28 Cr | 0.15 Cr | — |
| Change In Other Current Liabilities | 0.24 Cr | 0.41 Cr | -92000.00 | 60000.00 | — |
| Change In Other Current Assets | -0.94 Cr | -1.46 Cr | 0.20 Cr | -0.13 Cr | — |
| Change In Payable | 0.28 Cr | -0.05 Cr | -0.12 Cr | 0.06 Cr | — |
| Change In Inventory | -0.24 Cr | -0.14 Cr | 0.01 Cr | -0.07 Cr | — |
| Change In Receivables | -1.07 Cr | -0.73 Cr | -0.11 Cr | 0.23 Cr | — |
| Other Non Cash Items | -0.09 Cr | 0.07 Cr | -0.04 Cr | -0.07 Cr | — |
| Depreciation And Amortization | 0.45 Cr | 0.44 Cr | 0.45 Cr | 0.38 Cr | — |
| Depreciation | 0.45 Cr | 0.44 Cr | 0.44 Cr | 0.38 Cr | — |
| Gain Loss On Sale Of PPE | -0.07 Cr | 0.00 | — | — | — |
| Net Income From Continuing Operations | 0.55 Cr | 0.51 Cr | 0.86 Cr | 0.70 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | -1000.00 | — | — | — |
| Dividends Received Cfi | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Investment Purchase And Sale | — | 1.95 Cr | -1.88 Cr | -0.05 Cr | 0.59 Cr |
| Amortization Cash Flow | — | — | 31000.00 | 2000.00 | 12000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Clinitech Laboratory Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.